[1]Chen HY , Lei XY, Yuan DJ, et al . The relationship between the minor allele content and Alzheimer's disease . Genomics . 2020 Jan; 112(3):2426-2432 .
[2]Qiao O, Ji H, Zhang Y, et al . New insights in drug development for Alzheimer's disease based on microglia function . Biomedicine & Pharmacotherapy.2021 Aug;140(4) .
[3]Yang Y, Tapias V, Acosta D, et al . Succinylation links metabolic reductions to amyloid and tau patholo- gy. Cold Spring Harbor Laboratory. 2019.
[4]Patterson C . World Alzheimer Report 2018 —The state of the art of dementia research: New frontiers . Alzheimer’s Disease International . 2018.
[5]Sharma A, Dey P. A machine learning approach to unmask novel gene signatures and prediction of Alzheimer's disease within different brain regions . Genomics .2021 Apr ;113(4):1778- 1789 .
[6]Hasan B , Khan A , Lenz C , et al . Characterization of functional protein complexes from Alzheimer's disease and healthy brain by mass spectrometry-based proteome analysis . Scientific Reports .2021 .
[7]Zhang XJ, Song WH . The role of APP and BACE1 trafficking in APP processing and amyloid- β genera- tion . Alzheimer's Research & Therapy. 2013 Oct;5(5) .
[8]Johnson GV, Stoothoff WH . Tau phosphorylation in neuronal cell function and dysfunction . Journal of Cell Science .2004 Nov;117(24):5721-5729 .
[9]Karahan H, Smith DC, Kim B, et al . Deletion of Abi3 gene locus exacerbates neuropathological features of Alzheimer's disease in a mouse model of Aβ amyloidosis .Sci Adv.2021,7(45) .
[10]Bing B, Xusheng W, Yuxin L, et al . Deep multilayer brain proteomics identifies molecular networks in Alzheimer's disease progression . Neuron . 2020 May;106(4) .
[11]Vincent, Chouraki, Sarah R, et al . Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study. Alzheimer's & Dementia .2017 Apr ;13(12):1327- 1336 .
[12]Varma VR, Oommen AM, Varma S, et al . Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. Plos Medicine .2018 Jan;15(1) .
[13]Horgusluoglu E, Neff R, Song WM, et al . Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease .Alzheimers Dement .2021 .
[14]Pan R Y, He L, Zhang J, et al . Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer's disease .Social Science Electronic Publishing . 2022 Apr ;34(4):634-648 .
[15]Haytural H , Mermelekas G , Emre C, et al . The Proteome of the dentate terminal zone of the perforant path indicates presynaptic impairment in alzheimer disease . Molecular & Cellular Proteomics .2019,19(1).
[16]Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration .- Cell .2020 Jan;19(1):128- 141 .
[17]Zhang Q, Li L, Ma C, et al . Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer's disease .Science Advances .2020 Oct;6(40) .
